Hans-G. Klingemann

Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells.

Jiang-Hong Gong, Guitta Maki, Hans-G. Klingemann · PubMed · 1994 · 729 citations

Factors Regulating the Cytotoxic Activity of the Human Natural Killer Cell Line, NK-92

Guitta Maki, Hans-G. Klingemann, Jeffrey Martinson et al. · Journal of Hematotherapy & Stem Cell Research · 2001 · 263 citations

Cytogenetic Abnormalities in Primary Myelodysplastic Syndrome Are Highly Predictive of Outcome After Allogeneic Bone Marrow Transplantation

Thomas J. Nevill, Henry C. Fung, John D. Shepherd et al. · Blood · 1998 · 161 citations

Immunotherapy of Malignant Melanoma in a SCID Mouse Model Using the Highly Cytotoxic Natural Killer Cell Line NK-92

Ying K. Tam, Blythe Miyagawa, Vincent Ho et al. · Journal of Hematotherapy · 1999 · 129 citations

Mewo Melanoma Cells, Cancer Immunosurveillance, Scid Mouse Model +15

Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamide.

Donna Reece, Michael J. Barnett, J M Connors et al. · PubMed · 1993 · 55 citations